Physician profile
Michael H Shanik
NPI 1386775740
$1,190,304.99
in general payments reported to CMS, 2019-2025
90 companies · $321K in 2025
The $321K reported for 2025 was more than what 99% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184K · 2020: $116K · 2021: $83K · 2022: $176K · 2023: $131K · 2024: $180K · 2025: $321K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $523K · Honoraria: $41K · Food and Beverage: $28K · Travel and Lodging: $27K · Consulting Fee: $13K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $450 · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $522,512.18 |
| Honoraria | $40,721.75 |
| Food and Beverage | $28,289.17 |
| Travel and Lodging | $26,526.37 |
| Consulting Fee | $12,904.46 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $450.00 |
| Education | $101.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $338,181.78 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $215,813.76 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $149,342.21 | 2019-2025 | Evenity, Tepezza, Repatha |
| Madrigal Pharmaceuticals | $78,587.69 | 2024-2025 | Rezdiffra, Resmetirom |
| Ascendis Pharma Endocrinology INC | $67,925.65 | 2023-2025 | Yorvipath |
| Bayer Healthcare Pharmaceuticals INC. | $67,269.78 | 2021-2025 | |
| Abbott Laboratories | $64,159.17 | 2019-2025 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $51,379.18 | 2019-2023 | |
| Xeris Pharmaceuticals, INC. | $50,482.48 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40,847.55 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Corcept Therapeutics | $10,774.11 | 2019-2025 | Korlym |
| Recordati_rare_diseases_inc. | $10,253.48 | 2020-2025 | Isturisa, Signifor Lar |
| Chiesi USA, INC. | $7,843.10 | 2025 | Mycapssa |
| Janssen Pharmaceuticals, INC | $7,315.35 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $5,752.28 | 2019-2022 |
Show all 84 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clarus Therapeutics INC. | $3,282.53 | 2020-2021 | |
| Vivus LLC | $2,678.20 | 2019-2024 | Qsymia |
| Astrazeneca Pharmaceuticals Lp | $2,188.30 | 2019-2022 | |
| Bigfoot Biomedical INC | $2,130.28 | 2022-2023 | Unity Diabetes Management System |
| Medtronic Minimed, INC. | $1,590.34 | 2019 | |
| Alexion Pharmaceuticals, INC. | $1,403.09 | 2020-2025 | Strensiq |
| Sanofi-Aventis U.S. LLC | $1,027.86 | 2019-2025 | |
| Amneal Pharmaceuticals LLC | $934.23 | 2019-2025 | Unithroid |
| Radius Health, INC. | $807.68 | 2019-2025 | Tymlos |
| Insulet Corporation | $556.93 | 2019-2025 | Omnipod |
| Dexcom, INC. | $529.42 | 2019-2025 | Dexcom G6 Transmitter |
| Mannkind Corporation | $527.93 | 2019-2025 | Afrezza |
| Novartis Pharmaceuticals Corporation | $518.84 | 2022-2025 | |
| Abbvie INC. | $504.27 | 2019-2025 | Synthroid |
| Ibsa Pharma INC. | $439.71 | 2019-2025 | Tirosint, Licart, Tirosint |
| Kowa Pharmaceuticals America, INC. | $337.37 | 2019-2024 | Livalo, Seglentis |
| Antares Pharma, INC. | $323.84 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Tandem Diabetes Care, INC. | $320.80 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Vertex Pharmaceuticals Incorporated | $286.67 | 2020 | |
| Cequr Corporation | $285.48 | 2022-2025 | Cequr Simplicity |
| Medtronic, INC. | $222.01 | 2021-2024 | Minimed 780g |
| Amryt Pharma Holdings Ltd | $219.47 | 2022-2023 | Mycapssa |
| Horizon Therapeutics Plc | $211.48 | 2019-2023 | Tepezza |
| Esperion Therapeutics, INC. | $200.29 | 2020-2025 | Nexletol |
| Lifescan, INC. | $187.92 | 2019-2023 | |
| Genzyme Corporation | $182.00 | 2019-2020 | |
| Kyowa Kirin, INC. | $171.75 | 2024 | Crysvita |
| Regeneron Healthcare Solutions, INC. | $164.80 | 2019-2024 | Evkeeza |
| Verity Pharmaceuticals INC. | $150.56 | 2024-2025 | Tlando |
| Beta Bionics, INC. | $147.94 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Intuity Medical INC | $136.40 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Amphastar Pharmaceuticals, INC. | $133.12 | 2023-2025 | Baqsimi |
| Shire North American Group INC | $121.93 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.26 | 2021-2024 | Cycloset |
| Currax Pharmaceuticals LLC | $116.37 | 2020-2023 | Nexletol, Contrave, Nexlizet |
| Becton, Dickinson and Company | $113.45 | 2019-2022 | |
| Pfizer INC. | $107.74 | 2019-2025 | |
| Aytu Biopharma, INC. | $93.99 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $91.72 | 2020-2023 | Somatuline Depot |
| Eisai INC. | $81.37 | 2019 | |
| Glycomark, INC. | $73.04 | 2019 | |
| Ascensia Diabetes Care US INC. | $59.80 | 2021-2025 | |
| Acella Pharmaceuticals, LLC | $54.27 | 2023-2025 | NP Thyroid 60 |
| Zealand Pharma US, INC. | $38.25 | 2021-2022 | |
| Althera Pharmaceuticals LLC | $34.87 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $33.92 | 2021-2022 | |
| Medicomp INC | $30.41 | 2025 | Telepatch Cardiac Monitor |
| Neurocrine Biosciences, INC. | $25.85 | 2025 | |
| Eusa Pharma (US) LLC | $25.27 | 2022 | |
| Sandoz INC. | $23.20 | 2025 | Jubbonti |
| Almatica Pharma LLC | $21.70 | 2025 | Teriparatide |
| Averitas Pharma INC. | $21.30 | 2023 | Qutenza |
| Sequel Med Tech, LLC | $21.20 | 2025 | Twiist |
| Embecta Corp. | $20.94 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Avvisto Therapeutics, LLC | $19.65 | 2024 | Cycloset |
| Tolmar, INC. | $19.61 | 2025 | Jatenzo |
| Acerus Pharmaceuticals Corporation | $19.38 | 2022 | |
| Rgh Enterprises LLC | $19.00 | 2025 | |
| Glaxosmithkline, LLC. | $17.68 | 2025 | Shingrix, Arexvy |
| G Medical Diagnostic Services, INC. | $17.62 | 2022 | |
| Companion Medical, INC. | $17.00 | 2019 | |
| Rhythm Pharmaceuticals, INC. | $16.93 | 2025 | Imcivree |
| Valeritas, INC. | $15.83 | 2019 | |
| Echosens North America, INC. | $15.00 | 2019 | |
| Azurity Pharmaceuticals, INC. | $14.96 | 2023 | Adthyza |
| Alfasigma USA, INC. | $14.37 | 2021 | |
| Senseonics, Incorporated | $14.00 | 2019 | |
| Endo Pharmaceuticals INC. | $12.26 | 2021 | |
| Medicure Pharma INC. | $10.77 | 2019 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Shanik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.